Poly Medicure Ltd (POLYMED) Q1 FY27 Results Analysis: PAT Falls 8.4%, Employee Expenses Surge 70.6%

Poly Medicure Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 525.38 Cr (+30.30% YoY) and PAT growth of -8.40% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Standalone margins improved and met guidance, but consolidated PAT declined 8.4% due to acquisition cost layers and a 70.6% surge in employee expenses. The credit outlook upgrade to Positive is a positive signal, but acquisition integration and cost control remain key watch items.

Key Investment Insights

Key Positives

• Standalone EBITDA margin improved 154 bps YoY to 28.03%, at the upper end of the 25-27% guidance band
• Consolidated revenue grew 30.3% YoY to Rs.525.38 Cr
• Consolidated EBITDA margin recovered 3.1 ppt QoQ to 24.11%, within the 23-25% guidance band
• CRISIL rating outlook revised to Positive from Stable

Risk Factors

• Consolidated PAT declined 8.4% YoY to Rs.85.27 Cr despite 30% revenue growth
• Employee benefits expense surged 70.6% YoY on a consolidated basis
• Subsidiary EBITDA margin of ~6.2% is well below the group average, causing margin dilution